Spending in 2023 and 2024 increased by a similar percent, as increased demand for healthcare influenced this two-year trend.
Hosted on MSN
DGX Q2 Deep Dive: Acquisitions, Advanced Diagnostics, and Utilization Trends Drive Growth
Healthcare diagnostics company Quest Diagnostics (NYSE:DGX) reported Q2 CY2025 results , with sales up 15.2% year on year to $2.76 billion. The company’s full-year revenue guidance of $10.86 billion ...
In a report released today, Patrick Wood from Morgan Stanley maintained a Buy rating on Intuitive Surgical (ISRG – Research Report), with a price target of $650.00. Patrick Wood’s rating is based on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback